Nicotinamide-like heart medicine given during stent helps blood flow
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies whether a medicine (nicorandil) given into a coronary artery during stent procedures can help keep blood flow from getting worse. It may help people having stent placement for coronary artery disease by improving how well blood moves through the treated area.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 19 years old
- Have had a stent procedure guided by NIRS-IVUS imaging for coronary artery disease
- Join willingly, follow the study schedule, and sign consent
- Start the stent procedure with a blood-flow score (TIMI) greater than 2
- Be able to take the study-related medicines and materials without true allergy (severe anaphylaxis to contrast is a no)
- Not be pregnant or planning pregnancy during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who need a coronary (heart) stent to see how they do after treatment. It does not sound like an experimental drug trial for you—it’s mainly about collecting health information after a stent procedure.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This study follows people who need a heart procedure to open narrowed coronary arteries using a drug-coated stent. It aims to see how well these stents work and how people do in everyday clinical practice.
This study tests a new imaging technique to help doctors see inside your heart arteries during a stent procedure. It may help guide treatment and improve outcomes for people with heart disease.
This trial tests a new heart stent called MiStent II to treat narrowed coronary (heart) arteries. It looks at whether the stent is safe and works well for people who need a procedure to restore blood flow.
This trial tests a special balloon to treat narrowed areas inside a previously placed heart stent. It may help by reopening the artery without adding another stent.
Hear when a new No-Reflow Phenomenon trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.